agilon health (NYSE:AGL) Trading Up 6.4% - Time to Buy?

agilon health, inc. (NYSE:AGL - Get Free Report) was up 6.4% during mid-day trading on Friday . The stock traded as high as $2.35 and last traded at $2.33. Approximately 281,456 shares traded hands during trading, a decline of 89% from the average daily volume of 2,576,343 shares. The stock had previously closed at $2.19.

Wall Street Analysts Forecast Growth

Several brokerages have commented on AGL. Macquarie assumed coverage on shares of agilon health in a report on Monday, December 16th. They issued a "neutral" rating and a $3.00 target price for the company. Citigroup raised agilon health from a "sell" rating to a "neutral" rating and raised their price objective for the company from $1.75 to $2.25 in a research note on Friday. Needham & Company LLC assumed coverage on agilon health in a research note on Friday. They issued a "hold" rating on the stock. Barclays dropped their price objective on shares of agilon health from $5.00 to $2.00 and set an "underweight" rating on the stock in a report on Monday, November 11th. Finally, Stifel Nicolaus decreased their price objective on agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a report on Tuesday, November 12th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $3.98.

agilon health Price Performance

The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market cap of $997.08 million, a P/E ratio of -2.57 and a beta of 0.53. The business has a 50-day moving average of $2.07 and a two-hundred day moving average of $3.79.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter last year, the company posted ($0.06) earnings per share. On average, sell-side analysts anticipate that agilon health, inc. will post -0.52 earnings per share for the current fiscal year.

Insider Activity

In other news, Director John William Wulf acquired 45,000 shares of the business's stock in a transaction on Thursday, December 5th. The shares were purchased at an average cost of $2.18 per share, with a total value of $98,100.00. Following the acquisition, the director now directly owns 206,133 shares of the company's stock, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Karen Mcloughlin bought 25,000 shares of the stock in a transaction dated Friday, December 13th. The stock was purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the acquisition, the director now owns 73,166 shares of the company's stock, valued at $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 90,000 shares of company stock valued at $198,100 in the last ninety days. 3.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On agilon health

A number of hedge funds and other institutional investors have recently made changes to their positions in AGL. AQR Capital Management LLC raised its position in agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company's stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC increased its holdings in agilon health by 65.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company's stock worth $5,262,000 after acquiring an additional 316,856 shares during the last quarter. Citigroup Inc. raised its stake in agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the period. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in agilon health in the 2nd quarter valued at about $1,849,000. Finally, Geode Capital Management LLC lifted its holdings in agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company's stock valued at $27,097,000 after purchasing an additional 84,889 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.